The Supreme Court rejected the lawsuit filed against the Food and Drug Administration that challenged the agency's approach to regulating the abortion pill mifepristone, thereby effectively allowing access to the drug without an in-person consultation.
In a unanimous decision, the Supreme Court permitted doctors to mail the pills to their patients even without an in-person visit. Justice Brett Kavanaugh wrote the opinion on the case, citing lack of standing as the grounds for the decision.
